BUZZ-Brokerages cut Aussie co ALS's PT, earnings outlook on weak forecast

Reuters09-20

(Adds comment from Jarden note, updates share moves)

** Brokerages slash PT and outlook for technical services provider ALS on weak H1 forecast

** Macquarie slashes PT by 7% to A$15, reduces FY25, 26 and 27 EPS estimates by 9%, 7% and 7%, respectively

** Expects co's exploration cycle to show recovery in CY25 after 2 down years, supported by a gradually improving economic activity post Fed's rate cuts

** Morningstar cuts FY25 net profit after tax (NPAT) forecast by 5% to A$295 mln ($201 mln), sees limited longer-term implications despite outlook downgrade

** Jarden lowers PT to A$14.20 from A$14.90, sees 7% decline in H1 core NPAT and 1% drop in FY25 core NPAT

** ALS up 2% at A$13.940

** Stock dropped 8.6% in its worst day in more than 4 years on Thursday as co expected a 5% reduction in HY underlying NPAT

** Stock gains 8.3% YTD

($1 = A$1.4671)

(Reporting by Ayushman Ojha in Bengaluru)

((Ayushman.ojha@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment